Skip to main content

Month: April 2024

Sunstone IV hf. – Annual financial report

Sunstone IV hf. announces consolidated condensed annual financial statements for the year ended 31 December 2023 Sunstone IV hf. Storhofdi 22-30110 Reykjavik, Iceland Sunstone IV hf. announces Consolidated Condensed Annual Financial Statements for the year ended 31 December 2023 Consolidated condensed annual financial statements, for the year 2023, ended 31 December 2023 of Sunstone IV hf. were approved at a Board of Directors meeting and Annual General Meeting on 4 April 2024. The financial statements are enclosed and can also be found on the Company’s website: Fjármálaupplýsingar Sunstone IV | Sunstone IV | Míla ehf (mila.is) For more information please contact: Inga Helga HalldórudóttirCompliance officerSunstone IV hf. regluvordur@mila.is 

Continue reading

North Bay Resources Announces Acquisition of 55.5% of Bishop Gold Mill, California, USA

SKIPPACK, Pa., April 08, 2024 (GLOBE NEWSWIRE) — North Bay Resources Inc. (the “Company” or “North Bay”) (OTC: NBRI) is pleased to announce it has entered into a share purchase agreement to acquire 55.5% of the Bishop Gold Mill, located six miles north of Bishop, Inyo County, California. The mill has a flotation circuit designed to process up to 96 tons per day. The Company proposes to operate the Bishop Gold Mill in the near to medium term. The mill is currently permitted for operation subject to various conditions and minor infrastructure completions. The Company has entered into an agreement with the note holder, CMC Metals Ltd. (TSXV: CMB) (“CMC”), and the current owner 1436132 BC Ltd., a private Canadian company, to acquire 55.5% of 0877887 BC Ltd. (“087”), whose primary asset is the Bishop Gold Mill. Within this transaction,...

Continue reading

Bango PLC (“Bango” or the “Company”) 2023 Full Year Results and 2024 Outlook

CAMBRIDGE, United Kingdom, April 08, 2024 (GLOBE NEWSWIRE) — Bango (AIM: BGO) today announces its full year results for the 12 months ended 31 December 2023 and provides an update on the outlook for 2024. FY23 Financial Overview:Results for the 12 months ended 31 December 2023  FY23 FY22 YoY Change       Transactional Revenue1 $32.7M $18.3M +79%DVM, Bango Audiences & One Off Revenue2 $13.4M $10.2M +31%       Total Revenue $46.1M $28.5M +62%       Annual Recurring Revenue (ARR) 3 $8.8M $5.0M +77%Net Retention4 137% – –       Adjusted EBITDA5 $6.4M $5.0M +29%       Loss After Tax ($8.8M) ($2.1M) ($6.7M)       Net (debt)/cash at 31 December6 ($3.9M) $12.7M ($16.6M)FY23 Operational highlights:9 new Digital Vending Machine® (‘DVM’) license customers (total 18 at end...

Continue reading

Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

BETHESDA, Md., April 08, 2024 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announces the appointment of Gene Mack, MBA as its chief financial officer, effective as of April 8, 2024. “We are thrilled to welcome Gene as our new CFO,” commented Gain CEO Matthias Alder. “His experience as an operational CFO with a track record of successful financing, M&A and other strategic transactions combined with his scientific background and career as an equity research analyst ideally complement our executive management team as we expand our outreach to the investor community and progress our lead drug candidate GT-02287 in the clinic.” Gene has over 25...

Continue reading

ASP Isotopes Inc. Enters Into a Contract with U.S.-Based Small Modular Reactor (SMR) Company for Project Focused on Engineering Design and Planning for Enrichment Facility for the Production of Advanced Nuclear Fuels

The contract focuses on preliminary engineering design and planning for an enrichment facility for the production of next generation nuclear fuels, and has an aggregate contract value of up to $2 million WASHINGTON, April 08, 2024 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of enriched isotopes for use in multiple industries, today announced that it has entered into a contract with a U.S.-based SMR (Small Modular Reactor) company, pursuant to which the Company will engage in certain activities related to preliminary engineering design and planning for an enrichment facility for the production of nuclear fuels that are expected to be used in next-generation nuclear reactors in exchange...

Continue reading

Invitation to the annual shareholders’ meeting

The annual shareholders’ meeting will be held on Tuesday April 30, 2024 at 4:00 pm CET at Bella Center, Center Boulevard 5, Denmark.The distribution of profit will be addressed at the meeting and the Board of Directors proposes an ordinary dividend of DKK 2 or EUR 0.27 per A/B share for the last four months (September 1 – December 31) of 2023. This equals a pay-out ratio of 53.2% of Novonesis’ adjusted net profit for the four-month period. Following the approval of the proposed dividend, legacy Novozymes shareholders will have received a total pay-out of the 2023 adjusted net profit of DKK 6.20 per share (50.8% pay-out ratio). This equals an increase in the paid dividend of 3% compared to the dividend paid for the 2022 result. The invitation to convene the annual shareholders’ meeting is attached in English and Danish.Attachments...

Continue reading

Aura Announces Strong Q1 2024 Production Results, 28% Above Q1 2023 and on track to deliver its 2024 Production Guidance

ROAD TOWN, British Virgin Islands, April 08, 2024 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA, B3: AURA33 and OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to announce Q1 2024 preliminary production results from the Company’s four operating mines: Aranzazu, Apoena (EPP), Minosa (San Andres), and Almas. Total production in Q1 2024 reached 68,181 gold equivalent ounces (“GEO”)1, stable compared to Q4 2023 and 28% above the same period of last year, mainly due to Minosa’s performance due to operational improvements in 2023, and Almas. At constant metal prices, production was stable compared to Q4 2023 and increased by 35% compared to Q1 2023. Total production for Q1 2024 was either at or above the Company’s expectations across all its operating mines, which positions the Company to remain on track to achieve Consolidated...

Continue reading

Studio City Finance Limited Announces Tender Offer for Up to US$100 Million of Its 6.000% Senior Notes due 2025

MACAU, April 08, 2024 (GLOBE NEWSWIRE) — Studio City Finance Limited (“Studio City Finance”) today announces that it has initiated a cash tender offer for up to an aggregate principal amount of US$100 million (the “Maximum Tender Amount”) of its outstanding 6.000% senior notes due 2025 (ISIN: US86389QAE26 and USG85381AE48) (the “Notes” and such tender offer, the “Tender Offer”). The Tender Offer is being made upon and is subject to the terms and conditions set out in the Offer to Purchase, dated April 8, 2024 (the “Offer to Purchase”). The Tender Offer will expire at 5:00 p.m., New York City time, on May 6, 2024, unless extended or terminated by Studio City Finance (the “Expiration Time”). Tenders of the Notes may be withdrawn at any time at or prior to 5:00 p.m., New York City time, on April 19, 2024 (the “Withdrawal Deadline”),...

Continue reading

Sustainable Green Team, Ltd.’s (SGTM) Bold Breakthrough, Revolutionizing Agriculture with Organic Pellet Fertilizer and Micro Encapsulation Technology

SGTM Interview on Bloomberg TVORLANDO, Fla., April 08, 2024 (GLOBE NEWSWIRE) — Sustainable Green Team, Ltd. (OTCQX: SGTM) ($SGTM) (“Company”), a leading provider of sustainable and eco-friendly products, announces the signing of a groundbreaking agreement granting the Company the option to purchase the trademark, patent rights, and intellectual property for a revolutionary organic fertilizer. With the agreement, SGTM can create pelletized organic fertilizers for easier handling and distribution. Additionally, the deal includes a method to encapsulate beneficial microbes, improving their effectiveness in the soil. This combination has the potential to revolutionize agriculture, providing sustainable agricultural solutions and enhancing soil qualities for farmers.Pelletized Organic Fertilizer The...

Continue reading

Regional Health Properties Reports Fourth Quarter and Full Year 2023 Financial Results

Collected 93% of Contractual Rent[1] Strong Operator Rent Coverage ATLANTA, GA, April 08, 2024 (GLOBE NEWSWIRE) — Regional Health Properties, Inc. (the “Company,” “Regional Health,” “we”, “us” or “our”) (NYSE American: RHE) (NYSE American: RHE-PA), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. FOURTH QUARTER 2023 FINANCIAL  · Generated $0.2 million of income from operations in the fourth quarter of 2023, compared to a loss from operations of $3.0 million in the fourth quarter of 2022  · Reduced net loss per share of common stock to $0.13 in the fourth quarter of 2023, compared to $2.54 for the fourth quarter of 2022  · Generated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.